-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Eucrates Biomedical Acquisition Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2020 to Q4 2022.
- Eucrates Biomedical Acquisition Corp. Nonoperating Income (Expense) for the quarter ending December 31, 2022 was $405K, a 16.1% decline year-over-year.
- Eucrates Biomedical Acquisition Corp. Nonoperating Income (Expense) for the twelve months ending December 31, 2022 was $3.12M, a 31.7% decline year-over-year.
- Eucrates Biomedical Acquisition Corp. annual Nonoperating Income (Expense) for 2022 was $3.12M, a 31.7% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)